1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Italy Pharmaceuticals and Healthcare Report Q2 2016

Italy Pharmaceuticals and Healthcare Report Q2 2016

  • February 2016
  • -
  • Business Monitor International
  • -
  • 60 pages

BMI View: The economic recovery that began in 2015 after a three year recession will gather momentumin 2016, although the recovery will remain relatively tepid. Employment will increase, as will consumerconfidence and this will provide a boost to the retail sector. However, because the recovery will berelatively tepid, we believe that essential spending will increase more rapidly than non-essential spending.Low inflation and low interest rates will also help to boost retail spending in 2016.

Key Views & Developments

- The economic recovery that began in 2015, when the Italian economy returned to positive growth afterthree years of recession, will gather momentum in 2016 and we expect headline economic growth toregister 1.2%, up from 0.8% in 2015.

Table Of Contents

Italy Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
SWOT 9
Industry Forecast 11
Headline Retail Forecast 11
Table: Total Household Spending (Italy 2013-2020) 12
Table: Retail Sector Spending, % Of Total (Italy 2013-2020) 12
Table: Retail Sector Spending, % of GDP (Italy 2013-2020) 14
Table: Headline Retail Sector Spending (Italy 2013-2020) 16
Retail Sector Forecast 17
Food, Drink And Tobacco Spending 19
Table: Food, Drink and Tobacco Spending (Italy 2013-2020) 19
Clothing And Footwear Spending 20
Table: Clothing and Footwear Spending (Italy 2013-2020) 20
Household Goods Spending 21
Table: Household Goods Spending (Italy 2013-2020) 21
Table: Consumer Electronics Spending (Italy 2013-2020) 23
Personal Care Spending 23
Table: Personal Care Spending (Italy 2013-2020) 24
Household Numbers and Income Forecast 24
Table: Household Income Data (Italy 2013-2020) 26
Demographic Forecast 28
Table: Total Population (Italy 2013-2020) 29
Table: Population: Babies (Italy 2013-2020) 30
Table: Population: Young Children (Italy 2013-2020) 30
Table: Population: Children (Italy 2013-2020) 30
Table: Population: Young Teens and Older Children (Italy 2013-2020) 31
Table: Population: Young People (Italy 2013-2020) 31
Table: Population: Older Teenagers (Italy 2013-2020) 31
Table: Population: 21yrs + (Italy 2013-2020) 32
Table: Population: Young Adults (Italy 2013-2020) 32
Table: Population: Middle Aged (Italy 2013-2020) 32
Table: Population: Urban (Italy 2013-2020) 33
Industry Risk Reward Ratings 34
Developed States Risk/Reward Index 34
Table: Developed States Retail Risk/Reward Index, Q216 34
Italy Risk/Reward Index 35
Rewards 35
Risks 36
Market Overview 38
Competitive Landscape 45
Table: Major Clothing And Footwear Retailers 45
Table: Household Goods Retailers 45
Table: Electronics Retailers 46
Table: Major E-commerce Retailers 46
Table: Pharmacies Retailers 46
Glossary 47
Methodology 54
Industry Forecast Methodology 54
Sources 57
Risk/Reward Index Methodology 57
Table: Retail Risk/Reward Index Indicators 58
Table: Weighting Of Indicators 60

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.